A Randomised, Double-Blind, Double-Dummy, Active and Placebo Controlled Phase 1 Study of the Safety, Tolerability and Immunogenicity of the Codavax Influenza Vaccine in healthy volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 May 2017
At a glance
- Drugs Influenza A virus H1N1 vaccine Codagenix (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; First in man
- Sponsors Codagenix
- 04 May 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Mar 2017 Status changed from not yet recruiting to recruiting.
- 21 Feb 2017 Status changed from planning to not yet recruiting.